CoChat

Asymptomatic Alzheimer disease: Defining resilience

Open access
Hohman, Timothy J., McLaren, Donald G., Mormino, Elizabeth C., Gifford, Katherine A., Libon, David J., Jefferson, Angela L., For the Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative, Weiner, Michael W., Petersen, Ron, Aisen, Paul, Jack, Clifford, Jagust, William, Shaw, Leslie M., Trojanowski, John, Beckett, Laurel, Toga, Art, Psy.D, Andrew Saykin, Morris, John C., Montine, Tom, Green, Robert · 2016 · Neurology
Cited by 83

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To define robust resilience metrics by leveraging CSF biomarkers of Alzheimer disease (AD) pathology within a latent variable framework and to demonstrate the ability of such metrics to predict slower rates of cognitive decline and protection against diagnostic conversion. METHODS: Participants with normal cognition (n = 297) and mild cognitive impairment (n = 432) were drawn from the Alzheimer's Disease Neuroimaging Initiative. Resilience metrics were defined at baseline by examining the residuals when regressing brain aging outcomes (hippocampal volume and cognition) on CSF biomarkers. A positive residual reflected better outcomes than expected for a given level of pathology (high resilience). Residuals were integrated into a latent variable model of resilience and validated by testing their ability to independently predict diagnostic conversion, cognitive decline, and the rate of ventricular dilation. RESULTS: ). These results were significant even when analyses were restricted to clinically normal individuals. Furthermore, resilience metrics interacted with biomarker status such that biomarker-positive individuals with low resilience showed the greatest risk of subsequent decline. CONCLUSIONS: Robust phenotypes of resilience calculated by leveraging AD biomarkers and baseline brain aging outcomes provide insight into which individuals are at greatest risk of short-term decline. Such comprehensive definitions of resilience are needed to further our understanding of the mechanisms that protect individuals from the clinical manifestation of AD dementia, especially among biomarker-positive individuals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000003397

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 83

Metadata

Authors
Hohman, T. J., McLaren, D. G., Mormino, E. C., Gifford, K. A., Libon, D. J., Jefferson, A. L., Initiative, F. T. A. D. N., Initiative, A. D. N., Weiner, M. W., Petersen, R., Aisen, P., Jack, C., Jagust, W., Shaw, L. M., Trojanowski, J., Beckett, L., Toga, A., Psy.D, A. S., Morris, J. C., Montine, T., & Green, R.
Venue
Neurology
Published
2016-12-06
Volume
87
Issue
23
Pages
2443-2450
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2547338783
Cited by
83
References
8
FWCI
4.14
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Asymptomatic Alzheimer disease: Defining resilience. https://app.cochat.ai/papers/10.1212/wnl.0000000000003397
The paper
Hohman, T. J., McLaren, D. G., Mormino, E. C., Gifford, K. A., Libon, D. J., Jefferson, A. L., Initiative, F. T. A. D. N., Initiative, A. D. N., Weiner, M. W., Petersen, R., Aisen, P., Jack, C., Jagust, W., Shaw, L. M., Trojanowski, J., Beckett, L., Toga, A., Psy.D, A. S., Morris, J. C., . . . Green, R. (2016). Asymptomatic Alzheimer disease: Defining resilience. Neurology. https://doi.org/10.1212/wnl.0000000000003397

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.